Une étude menée entre autres par des scientifiques de l’#Inserm a caractérisé pour la première fois des nouvelles formes de rejet de #greffe rénale et leur impact sur la survie à long terme des greffons rénaux. 1/4 Lire le communiqué : presse.inserm.fr/une-etude-inte… Alexandre Loupy

Happening now: session on innate immune system in antibody-mediated rejection, insights on DSA-negative kidney allograft microvascular inflammation #KidneyWk

Amazing session of clinicopathologic correlations on challenging cases #KidneyWk

Another great collaborative work from our team just published in NEJM analyzing over 16000 biopsies including over 2500 biopsies from 1000 pediatric recipients and providing insight into microvascular inflammation in kidney allograft. Check it out 👇 x.com/NEJM/status/18…

🌟 Thank you to everyone who made #KidneyWk 2024 unforgettable! Don’t forget to save the date for Kidney Week 2025—see you next year in Houston, TX! ✨

Thrilled to see EU-TRAIN Project's contributions featured in a recent study, which identifies phenotypes in kidney transplant recipients to enhance diagnostic precision and optimise patient care! Horizon Europe 🇪🇺 Alexandre Loupy x.com/NEJM/status/18…

#Recherche | Un nouveau type de rejet de greffe rénale découvert. Des chercheurs de l’Université Paris Cité, Inserm et Assistance Publique – Hôpitaux de Paris (AP-HP) identifient pour la première fois une inflammation microvasculaire dans le rejet de greffe rénale. En savoir plus : u-paris.fr/une-etude-inte…

[ 📰 Publication dans le NEJM ] 🔎 Une vaste étude internationale a été conduite à l'institut PITOR (Paris Institute for Transplantation and Organ Regeneration - Inserm U970, Université Paris Cité ) incluant plus de 16000 biopsies réalisées chez 7000 patients transplantés rénaux

💫Throwback to American Society of Nephrology #kidneywk in ☀️SanDiego this year-listening to Aurélie Sannier presenting the latest Paris Transplant Group NEJM on 🌎outcomes in patients with #mvi! Honored to now publish this commentary with oriol bestard at ESOTtransplant Transplant International 🚀frontierspartnerships.org/journals/trans…

Pleased to see our recent publication in NEJM on the clinical outcomes of microvascular inflammation featured by Louise Benning and oriol bestard in the News and Views Section of Transplant International

It was a pleasure to be part of the Advances in Transplant Medecine Symposium #Zagreb, presenting on liver transplant rejection. Great to participate and meet new colleagues from University Hospital Center Zagreb🇭🇷 @ProfNikolinaBašić-Jukić, Ivana Juric Aurélie Sannier Paris Transplant Group

It’s crazy how talking with a science buddy is simultaneously what’s most likely to move the project forward and the thing that’s least prioritized in our schedule.

Interested in our team’s NEJM publication on microvascular inflammation in kidney allografts and its clinical outcomes? Check out the coverage in The Pathologist, highlighting the key findings and the study’s impact. thepathologist.com/subspecialties…

Editors’ Choice 2024: Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis This study found that kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and

Our study on Microvascular Inflammation of Kidney Allografts and Clinical Outcomes is now published in print! 📖✨ Alongside it, a must-read editorial dives into the evolving landscape of antibody-mediated rejection nejm.org/doi/full/10.10… A summary 🧵👇

Three months after her breakthrough surgery at NYU Langone Health, Towana Looney, the longest-living recipient of a genetically engineered pig kidney, is headed back home to Alabama! Learn more about her journey: nyulangone.org/news/pig-kidne…

Dr. Robert Montgomery, director of the NYU Langone Transplant Institute, recently shared insights with The New York Times on the progress of #xenotransplantation and what doctors have learned from the handful of procedures performed since 2021. Read the story ⤵️ nytimes.com/2025/03/10/hea…